Insmed Planning 2025 Launch For Brensocatib In Bronchiectasis
The drug maker anticipates a smooth regulatory path and has already begun to rapidly expand its sales force across most of the US.
The drug maker anticipates a smooth regulatory path and has already begun to rapidly expand its sales force across most of the US.